Small Molecules
26 October 2015
Janssen Receives Positive CHMP Opinion Recommending EDURANT®▼ (rilpivirine) for the Treatment of Adolescents Aged 12 to26 October 2015
Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure24 October 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX™ – First Low Dose SoluMatrix® Meloxicam for Osteoarthritis Pain23 October 2015
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis22 October 2015
Cyclacel Doses First Patient in Phase 1 Trial of Its Novel CDK2/9 Inhibitor, CYC065, for the Treatment of Advanced Solid Tumors22 October 2015
Xenon Announces Its Partner Genentech Has Advanced GDC-0310, a Second Nav1.7 Inhibitor for Pain, Into Clinical Development22 October 2015
Exelixis Initiates Rolling Submission of U.S. New Drug Application for Cabozantinib for the Treatment of Advanced Kidney Cancer22 October 2015
OXiGENE Announces Initiation of Phase 1b/2 Clinical Trial of OXi4503 in Acute Myeloid Leukemia22 October 2015
Oncodesign Presents Novel LRRK2 Inhibitor Jointly Discovered with Ipsen at the 2015 Neurosciences Meeting in Chicago21 October 2015
Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-30221 October 2015
Gilead Provides Update on Investigational Compound, GS-5734, for the Treatment of Ebola Virus Disease21 October 2015
Synta Announces Termination for Futility of Ganetespib Phase 3 GALAXY-2 Trial in Lung Cancer20 October 2015
Foamix Announces Enrollment of First Patient in Phase 2 Clinical Trial of FMX103 in Papulopustular Rosacea20 October 2015
Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor NBI-98854 in Adults with Tourette Syndrome20 October 2015
Tris Pharma Receives FDA Approval of Dyanavel™ XR (amphetamine) CII as Once-Daily Liquid for Treatment of ADHD in Children20 October 2015
Flex Pharma Demonstrates Single Agent Efficacy and Dose Response in Reducing Human Muscle CrampsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports